MYC and colorectal cancer: In this work, the PROTAC of BRD4 (dBET57) was found to downregulate colorectal cancer glycolysis through the transcription inhibition of c‐Myc, which could also inhibit the expression of PD‐L1 to reverse immune evasion and avoid adaptive immune resistance Scheme1.